Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.16 -0.07 (-0.68%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrendsBuy This Stock OACC vs. AC, PLYM, GETY, KREF, ABL, BRSP, ORC, AACT, PAX, and NOAHShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Associated Capital Group (AC), Plymouth Industrial REIT (PLYM), Getty Images (GETY), KKR Real Estate Finance Trust (KREF), Abacus Life (ABL), BrightSpire Capital (BRSP), Orchid Island Capital (ORC), Ares Acquisition Co. II (AACT), Patria Investments (PAX), and Noah (NOAH). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. Associated Capital Group Plymouth Industrial REIT Getty Images KKR Real Estate Finance Trust Abacus Life BrightSpire Capital Orchid Island Capital Ares Acquisition Co. II Patria Investments Noah Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Associated Capital Group (NYSE:AC) are both small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, community ranking, risk, institutional ownership and dividends. Does the media refer more to OACC or AC? In the previous week, Associated Capital Group had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 2 mentions for Associated Capital Group and 0 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Associated Capital Group's score of 0.00 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media. Company Overall Sentiment Oaktree Acquisition Corp. III Life Sciences Very Positive Associated Capital Group Neutral Do insiders & institutionals hold more shares of OACC or AC? 8.1% of Associated Capital Group shares are owned by institutional investors. 87.6% of Associated Capital Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is OACC or AC more profitable? Associated Capital Group has a net margin of 336.45% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Associated Capital Group's return on equity of 4.88% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A Associated Capital Group 336.45%4.88%4.62% Which has better earnings and valuation, OACC or AC? Associated Capital Group has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AAssociated Capital Group$13.18M61.94$44.33M$2.0718.56 Does the MarketBeat Community believe in OACC or AC? Associated Capital Group received 128 more outperform votes than Oaktree Acquisition Corp. III Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperformOaktree Acquisition Corp. III Life SciencesN/AN/AAssociated Capital GroupOutperform Votes12852.24% Underperform Votes11747.76% SummaryAssociated Capital Group beats Oaktree Acquisition Corp. III Life Sciences on 8 of the 9 factors compared between the two stocks. Remove Ads Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesHolding Offices Industry SectorNASDAQ ExchangeMarket Cap$229.41M$438.63M$2.49B$7.86BDividend YieldN/A7.54%13.10%4.06%P/E RatioN/A2.1411.4018.67Price / SalesN/A55.083,808,053.9887.31Price / CashN/A69.0168.0434.64Price / BookN/A3.423.164.09Net IncomeN/A$35.22M-$275.25M$246.93M7 Day Performance-0.29%-1.92%-1.81%-3.79%1 Month Performance1.20%-2.34%-2.40%-6.74%1 Year PerformanceN/A14.93%2.36%-1.88% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.16-0.7%N/AN/A$229.41MN/A0.00N/APositive NewsACAssociated Capital Group2.5599 of 5 stars$38.30+0.5%N/A+17.2%$813.27M$13.18M18.5020PLYMPlymouth Industrial REIT3.7037 of 5 stars$16.77-0.2%$22.00+31.2%-27.4%$764.57M$198.36M839.2540Analyst ForecastShort Interest ↑GETYGetty Images3.8446 of 5 stars$1.83-5.4%$4.60+152.1%-58.2%$752.94M$939.29M15.211,700KREFKKR Real Estate Finance Trust4.1631 of 5 stars$10.89-2.4%$12.46+14.5%+7.4%$747.95M$155.17M60.47N/ANews CoveragePositive NewsABLAbacus Life3.4282 of 5 stars$7.64+6.9%$14.30+87.2%-38.5%$738.37M$102.41M-42.4482Earnings ReportAnalyst RevisionNews CoverageHigh Trading VolumeBRSPBrightSpire Capital2.5927 of 5 stars$5.65-2.5%$7.69+36.2%-19.1%$732.20M$347.22M-5.3850ORCOrchid Island Capital4.7139 of 5 stars$7.65-3.8%$9.50+24.3%-15.6%$714.17M$54.41M12.762,018AACTAres Acquisition Co. IIN/A$11.16-0.2%N/A+5.5%$697.19MN/A0.00N/APositive NewsPAXPatria Investments3.1669 of 5 stars$11.42-1.4%$14.00+22.5%-23.9%$683.85M$374.20M22.88390NOAHNoah4.3327 of 5 stars$10.06-3.5%$12.17+20.9%-17.0%$663.70M$2.60B8.602,583Earnings ReportPositive News Remove Ads Related Companies and Tools Related Companies Associated Capital Group Competitors Plymouth Industrial REIT Competitors Getty Images Competitors KKR Real Estate Finance Trust Competitors Abacus Life Competitors BrightSpire Capital Competitors Orchid Island Capital Competitors Ares Acquisition Co. II Competitors Patria Investments Competitors Noah Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACC) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OACC Stock Free OACC Stock Alerts